McKinsey Drove Opioid Sale Scheme, Endo Ch. 11 Trust Says
Consulting giant McKinsey & Co. should pay at least $1.5 billion to cover costs pharmaceutical developer Endo International racked up defending against claims that it helped drive the opioid crisis, an...To view the full article, register now.
Already a subscriber? Click here to view full article